在胃肠道筋瘤中新辅助治疗策略
Dominic J Vitello1, Jeffrey D Wayne2
1Department of Surgery, Northwestern University Feinberg School of Medicine, 676 North Saint Clair Street, Arkes 650, Chicago, IL 60611, USA.
新辅助疗法 (NAT) 是一种正在发展中的胃肠道 stromal 瘤 (GIST) 的治疗方法. 在NAT之前,基因检测至关重要,NAT旨在减少手术并发症,并通过成像监测,随后进行长期全身治疗.
科学领域:
- 胃肠道瘤学 胃肠道瘤学
- 手术瘤学手术瘤学
- 医学瘤学 医学瘤学
背景情况:
- 胃肠道 stromal 瘤 (GIST) 是胃肠道的一种罕见的介质细胞瘤.
- 新辅助疗法 (NAT) 越来越多地用于GIST管理.
- 对GIST的最佳治疗策略正在不断发展.
研究的目的:
- 概述GIST管理中新辅助疗法的当前范式.
- 强调在NAT之前进行基因测试的重要性.
- 描述对GISTs的反应评估和治疗持续时间.
主要方法:
- 关于GIST NAT的当前临床实践和文献的审查.
- 对于接受NAT的GIST患者的基因检测协议.
- 放射性评估方法 (CT/MRI) 用于监测NAT反应.
- 在GIST切除后的全身治疗方案.
主要成果:
- 在GIST中,NAT主要旨在降低手术发病率.
- 对NAT的反应通常使用对比度增强的CT或MRI进行评估.
- 对NAT的最大反应通常在8-12个月内实现.
- 切除术后的全身治疗建议在选择的患者身上持续3年.
结论:
- 新辅助疗法代表了GIST管理的重大进步.
- 在治疗前进行基因检测对于指导GIST治疗至关重要.
- 对NAT响应评估和持续时间的结构化方法对于最佳结果至关重要.
- 长期的全身治疗和监测是全面GIST护理的组成部分.
更多相关视频
05:16Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
Published on: February 19, 2022
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Targeted Cancer Therapies
There are several types of targeted therapies against...
